Scarica l'app Stockscreener
26.93
5.77%
-1.65
Precedente Chiudi:
$28.58
Aprire:
$28.99
Volume 24 ore:
948.81K
Relative Volume:
0.69
Capitalizzazione di mercato:
$968.73M
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.4449
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
-11.09%
1M Prestazione:
-31.45%
6M Prestazione:
+87.01%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$26.16
$28.99
Intervallo di 1 settimana:
$26.16
$33.49
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
26.93 | 968.73M | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing
FDA approval remains Holy Grail for Aussie biotechs - NT News
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead
Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks
Have Insiders Sold GRAIL Shares Recently? - Simply Wall St
Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia
Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada
Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India
Grail president Joshua Ofman sells $65,800 in common stock - Investing.com
Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Longview News-Journal
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Why Grail (GRAL) Is Falling Today - MSN
Van ECK Associates Corp Takes $475,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail initiated at equal weight by Morgan Stanley - MSN
Can GRAIL's Cancer Detection Technology Transform Healthcare? Key Presentation Coming March 4 - StockTitan
Putting early cancer detection to the test - Nature.com
GRAIL to Present at TD Cowen 45th Annual Health Care Conference - WV News
GRAIL Q4 Loss Narrows, Revenue Up; Shares Rise After-Hours -February 20, 2025 at 05:36 pm EST - Marketscreener.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges - Investing.com
Earnings call transcript: Grail’s Q4 2024 revenue rises, stock surges By Investing.com - Investing.com Nigeria
Grail reports Q4 EPS ($2.89) vs. ($6.04) last year - TipRanks
Earnings call transcript: Grail's Q4 2024 revenue rises, stock surges By Investing.com - Investing.com UK
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (GRAL) GRAIL INC. Posts Q4 Revenue $38.3M, vs. FactSet Est of $34.4M - Marketscreener.com
Can GRAIL's 137,000 Cancer Test Sales Overcome Its $2B Loss? Key Earnings Insights - StockTitan
Grail Inc options imply 13.5% move in share price post-earnings - TipRanks
Golden Grail Beverages Announces Termination of UPDC Beverages Asset Purchase Agreement - GlobeNewswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges - The Globe and Mail
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance
Grail Inc expected to post a loss of $7.05 a shareEarnings Preview - TradingView
Grail, Inc. (NASDAQ:GRAL) Short Interest Update - Defense World
Grail rallies 30% in wake of Quest agreement - MSN
Grail (NASDAQ:GRAL) Trading 5.4% HigherWhat's Next? - MarketBeat
Moloney Securities Asset Management LLC Invests $559,000 in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Grail Inc Azioni (GRAL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ofman Joshua J. | President |
Mar 07 '25 |
Sale |
31.20 |
2,109 |
65,801 |
559,673 |
| Freidin Aaron | Chief Financial Officer |
Mar 07 '25 |
Sale |
31.20 |
1,816 |
56,659 |
335,170 |
0.80%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):